Home  ■  Participation  ■  Assessments  ■  Epitopes  ■  Protocols  ■  Techniques  ■  Links

Participation

New participant

Click on New participant if you wish to enrol for the first time. When accepted by NordiQC, a participant number and password is e-mailed within a few days.

Before filling out the form, please read the conditions for participation in

Subscription and Assessment method

Participant data

Click on Participant data to check information about names etc. and modify when needed. Include up to four contact persons (at least three is recommended).
For registered participants only. Password protected.

Protocol form 1

General module

Protocol form 1 (General module) is used for submission of protocols for Run 24 opening as of 1 September 2008 (an e-mail alert is sent to all participants). Protocols can NOT be submitted now. Deadline is 15 September. In case a laboratory changes a protocol before staining a NordiQC slide, a new protocol must be submitted to overwrite the first protocol. Password protected.

Protocol form 2

Breast module

Protocol form 2 (Breast module) is used for submission of protocols for Run B6 opening as of 1 September 2008 (an e-mail alert is sent to all participants). Protocols can NOT be submitted now. Deadline is 15 September. In case a laboratory changes a protocol before staining a NordiQC slide, a new protocol must be submitted to overwrite the first protocol. Password protected.

Protocol form 3

Workshop

Protocol form 3 (Workshop) is used for submission of protocols for the NordiQC Workshop Protocols can be submitted now. Deadline is 15 July. In case a laboratory changes a protocol before staining a NordiQC slide, a new protocol must be submitted to overwrite the first protocol. Password protected.

 

Scheme 2008 modules

General module

Events

Run 22

Run 23

Run 24

Epitopes to be detected1)
 

 CD3, CD15, CDX2,

CGA, MSH2, SYP

 CR, Ep-CAM, IgK,

IgM, TTF-1

 CD5, CD23, CK-Pan,

MLA, OCT3/4, PLAP

NordiQC: Advertising the new run

01 January2)

01 April

01 September

Participant: Deadline for protocol submission

15 January3)

15 April

15 September

NordiQC: Circulation of unstained slides

23 January4)

23 April

23 September

Participant: Deadline for return of stained slides

10 February

10 May

10 October

NordiQC: Assessment date (approx.)

21 February5)

21 May

21 October
NordiQC: Upload of general results and submission of individual results 07 April 07 July 07 December

1) If a laboratory does not stock an antibody to an epitope included, it cannot be replaced by another. 2) All dates indicated are approximate and may be changed by NordiQC if needed. Changes will appear on this site. 3) Also deadline for enrolment.  4) Also billing. 5) Also deadline for payment.

Abbreviations: CDX2: Caudal related homeobox-2; CK-Pan: Pan- or broad spectrum cytokeratin (the Ab should detect at least one primary/constitutive CK of simple epithelia, i.e., CK8 or CK18, and one primary/constitutive CK of squamous epithelia, i.e., CK5 or CK14); CGA: Chromogranin A; CR: Calretinin; Ep-CAM: Epithelial cell-cell adhesion molecule (e.g., Ber-EP4 or MOC31); IgK: Immunoglobulin kappa; IgM: Immunoglobulin M; MLA: Melan A; MSH2: Mut-S homologue; 2OCT3/4: Octamer transcription factor 3/4; PLAP: Placental alkaline phosphatase; SYP: Synaptophysin; TTF-1: Thyroid transcription factor-1.

 

Breast module

Events

Run B5

Run B6

Epitopes to be detected1)

 ECAD, ER, HER-21) CK-HMW, HER-21), PR

NordiQC: Advertising the new run

 01 April2)

01 September

Participant: Deadline for protocol submission

 15 April3)

15 September

NordiQC: Circulation of unstained slides

 23 April4)

23 September

Participant: Deadline for return of stained slides

 10 May

10 October

NordiQC: Assessment date (approx.)

 21 May5)

21 October
NordiQC: Upload of general results and submission of individual results 07 July 07 December
1) If a laboratory is unable to stain for HER-2, it can be replaced by PR in Run B5 and ER in Run B6. Use the field "Other epitope" in the protocol form. If a laboratory does not stock an antibody to E-cadherin, it cannot be replaced by another.2) All dates indicated are approximate and may be changed by NordiQC if needed. Changes will appear on this site. 3) Also deadline for enrolment.  4) Also billing. 5) Also deadline for payment.

Abbreviations: CK-HMW: Cytokeratin high molecular weight (the Ab should detect at least one primary/constitutive CK of of squamous epithelia, i.e., CK5 or CK14); ECAD: E-cadherin; ER: Estrogen receptor; PR: Progesterone receptor
 

¤ The dates indicated are approximate and may be changed by NordiQC if needed. Changes will appear on this site.
 

Previous modules
MV/AS

ADM

Last update 08-06-2008